University of Tasmania
Browse

File(s) not publicly available

Drug evaluation: VX-702, a MAP kinase inhibitor for rheumatoid arthritis and acute coronary syndrome

journal contribution
posted on 2023-05-23, 00:43 authored by Chang-Hai DingChang-Hai Ding
No description available

History

Publication title

Current Opinion in Investigational Drugs

Volume

7

Issue

11

Pagination

1020-1025

Department/School

Menzies Institute for Medical Research

Place of publication

The Thomson Corporation

Repository Status

  • Restricted

Socio-economic Objectives

Other health not elsewhere classified

Usage metrics

    University Of Tasmania

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC